198 related articles for article (PubMed ID: 30580105)
61. Platelet transfusion: a clinical practice guideline from the AABB.
Kaufman RM; Djulbegovic B; Gernsheimer T; Kleinman S; Tinmouth AT; Capocelli KE; Cipolle MD; Cohn CS; Fung MK; Grossman BJ; Mintz PD; O'Malley BA; Sesok-Pizzini DA; Shander A; Stack GE; Webert KE; Weinstein R; Welch BG; Whitman GJ; Wong EC; Tobian AA;
Ann Intern Med; 2015 Feb; 162(3):205-13. PubMed ID: 25383671
[TBL] [Abstract][Full Text] [Related]
62. [Therapeutic possibilities in the management of gastrointestinal bleeding in thrombocytopenic patients].
Gurzó M; Varga G; Dobos K; Náfrádi J; Petri A
Orv Hetil; 1994 Apr; 135(15):805-8. PubMed ID: 8177598
[TBL] [Abstract][Full Text] [Related]
63. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
Steensma DP; Abedi M; Bejar R; Cogle CR; Foucar K; Garcia-Manero G; George TI; Grinblatt D; Komrokji R; Ma X; Maciejewski J; Pollyea DA; Savona MR; Scott B; Sekeres MA; Thompson MA; Swern AS; Nifenecker M; Sugrue MM; Erba H
BMC Cancer; 2016 Aug; 16():652. PubMed ID: 27538433
[TBL] [Abstract][Full Text] [Related]
64. Demographic, Hematologic, and Clinical Features of Myelodysplastic Syndrome Patients: Results from the First Polish Myelodysplastic Syndrome Registry.
Mądry K; Machowicz R; Waszczuk-Gajda A; Drozd-Sokołowska J; Hołowiecka BS; Wiater E; Mital A; Obara A; Szmigielska-Kapłon A; Kołkowska-Leśniak A; Sikorska A; Subocz E; Mendrek W; Szczepańska M; Biedroń M; Jachalska A; Wasilewska E; Wojciechowska M; Guzicka-Kazimierczak R; Kopacz A; Katinas K; Kruger W; Dawidowska A; Salamańczuk Z; Zawirska D; Świderska A; Jędrzejczak WW; Dwilewicz-Trojaczek J
Acta Haematol; 2015; 134(2):125-34. PubMed ID: 25925777
[TBL] [Abstract][Full Text] [Related]
65. The incidence and impact of thrombocytopenia in myelodysplastic syndromes.
Kantarjian H; Giles F; List A; Lyons R; Sekeres MA; Pierce S; Deuson R; Leveque J
Cancer; 2007 May; 109(9):1705-14. PubMed ID: 17366593
[TBL] [Abstract][Full Text] [Related]
66. Platelet associated IgG may be related with thrombocytopenia in patients with myelodysplastic syndromes.
Gilli SC; de Souza Medina S; de Castro V; Fernandes LG; Saad ST
Leuk Res; 2012 May; 36(5):554-9. PubMed ID: 22129476
[TBL] [Abstract][Full Text] [Related]
67. A consistent approach to platelet transfusion in the NICU.
Del Vecchio A; Motta M; Radicioni M; Christensen RD
J Matern Fetal Neonatal Med; 2012 Oct; 25(Suppl 5):93-6. PubMed ID: 23025779
[TBL] [Abstract][Full Text] [Related]
68. Different Platelet Count Thresholds to Guide Use of Prophylactic Platelet Transfusions for Patients With Hematological Disorders After Myelosuppressive Chemotherapy or Stem Cell Transplantation.
Estcourt LJ; Stanworth SJ; Murphy MF
JAMA Oncol; 2016 Aug; 2(8):1091-2. PubMed ID: 27415031
[TBL] [Abstract][Full Text] [Related]
69. [Thrombocytopenia].
Gadó K; Domján G
Orv Hetil; 2014 Feb; 155(8):291-303. PubMed ID: 24534877
[TBL] [Abstract][Full Text] [Related]
70. Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia.
Kantarjian H; Fenaux P; Sekeres MA; Becker PS; Boruchov A; Bowen D; Hellstrom-Lindberg E; Larson RA; Lyons RM; Muus P; Shammo J; Siegel R; Hu K; Franklin J; Berger DP
J Clin Oncol; 2010 Jan; 28(3):437-44. PubMed ID: 20008626
[TBL] [Abstract][Full Text] [Related]
71. A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger.
Zumberg MS; del Rosario ML; Nejame CF; Pollock BH; Garzarella L; Kao KJ; Lottenberg R; Wingard JR
Biol Blood Marrow Transplant; 2002; 8(10):569-76. PubMed ID: 12434952
[TBL] [Abstract][Full Text] [Related]
72. A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia.
Heddle NM; Cook RJ; Tinmouth A; Kouroukis CT; Hervig T; Klapper E; Brandwein JM; Szczepiorkowski ZM; AuBuchon JP; Barty RL; Lee KA;
Blood; 2009 Feb; 113(7):1564-73. PubMed ID: 19109560
[TBL] [Abstract][Full Text] [Related]
73. Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions.
Friedmann AM; Sengul H; Lehmann H; Schwartz C; Goodman S
Transfus Med Rev; 2002 Jan; 16(1):34-45. PubMed ID: 11788928
[TBL] [Abstract][Full Text] [Related]
74. Neonatal Platelet Transfusions and Future Areas of Research.
Sola-Visner M; Bercovitz RS
Transfus Med Rev; 2016 Oct; 30(4):183-8. PubMed ID: 27282660
[TBL] [Abstract][Full Text] [Related]
75. Outcomes of endoscopic intervention for overt GI bleeding in severe thrombocytopenia.
Ramos GP; Binder M; Hampel P; Braga Neto MB; Sunjaya D; Al Bawardy B; Abu Dayyeh BK; Buttar NS; Bruining DH; Prabhu-Coelho N; Larson MV; Wong Kee Song LM; Rajan E
Gastrointest Endosc; 2018 Jul; 88(1):55-61. PubMed ID: 29408558
[TBL] [Abstract][Full Text] [Related]
76. Prophylactic platelet transfusion in children with thrombocytopenic disorders: a retrospective review.
Ferrara M; Capozzi L; Coppola A; Save G; Coppola L
Hematology; 2007 Aug; 12(4):297-9. PubMed ID: 17654055
[TBL] [Abstract][Full Text] [Related]
77. Thrombocytopenia in the intensive care unit-diagnostic approach and management.
Thiele T; Selleng K; Selleng S; Greinacher A; Bakchoul T
Semin Hematol; 2013 Jul; 50(3):239-50. PubMed ID: 23953341
[TBL] [Abstract][Full Text] [Related]
78. Preprocedural platelet transfusion for patients with thrombocytopenia undergoing interventional radiology procedures is not associated with reduced bleeding complications.
Warner MA; Woodrum D; Hanson A; Schroeder DR; Wilson G; Kor DJ
Transfusion; 2017 Apr; 57(4):890-898. PubMed ID: 28130779
[TBL] [Abstract][Full Text] [Related]
79. Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?
Stanworth SJ; Hyde C; Brunskill S; Murphy MF
Br J Haematol; 2005 Dec; 131(5):588-95. PubMed ID: 16351634
[TBL] [Abstract][Full Text] [Related]
80. Profound thrombocytopenia and survival of hematopoietic stem cell transplant patients without clinically significant bleeding, using prophylactic platelet transfusion triggers of 10 x 10(9) or 20 x 10(9) per L.
Nevo S; Fuller AK; Zahurak ML; Hartley E; Borinsky ME; Vogelsang GB
Transfusion; 2007 Sep; 47(9):1700-9. PubMed ID: 17725737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
